Shigeki Katoh Selected Research

Antigens

1/2021	Critical Involvement of CD44 in T Helper Type 2 Cell-Mediated Eosinophilic Airway Inflammation in a Mouse Model of Acute Asthma.
1/2017	Hyper-reactive cloned mice generated by direct nuclear transfer of antigen-specific CD4+ T cells.
9/2016	Critical role of CD44 in antigen-induced Th2- but not Th17-madiated murine airway inflammation.
12/2013	Preventive effect of galectin-9 on double-stranded RNA-induced airway hyperresponsiveness in an exacerbation model of mite antigen-induced asthma in mice.
10/2013	Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model.
1/2012	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.
11/2011	CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice.
7/2004	A possible role of TARC in antigen-specific Th2-dominant responses in patients with Paragonimiasis westermani.
5/2003	A role for CD44 in an antigen-induced murine model of pulmonary eosinophilia.
3/2003	Critical role of IL-5 in antigen-induced pulmonary eosinophilia, but not in lymphocyte activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeki Katoh Research Topics

Disease

19	Inflammation (Inflammations) 11/2022 - 03/2003
11	Asthma (Bronchial Asthma) 01/2023 - 07/2007
8	Respiratory Hypersensitivity 11/2022 - 03/2003
6	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 09/2020 - 03/2003
3	Idiopathic Pulmonary Fibrosis 09/2020 - 04/2013
3	Pneumonia (Pneumonitis) 12/2017 - 02/2010
2	Sarcoidosis (Schaumann Disease) 09/2020 - 12/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2018 - 01/2007
1	Allergic Bronchopulmonary Aspergillosis 01/2023
1	Lung Diseases (Lung Disease) 09/2020
1	Atopic Dermatitis (Atopic Eczema) 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Carrington syndrome 12/2017
1	Immune System Diseases (Immune Disorders) 01/2017
1	Human Influenza (Influenza) 01/2014
1	Infections 01/2014
1	Hypersensitivity (Allergy) 10/2013
1	Vascular Diseases (Vascular Disease) 04/2013
1	Idiopathic Interstitial Pneumonias 04/2013
1	Cough 03/2011
1	Atherosclerosis 02/2009
1	Neoplasms (Cancer) 09/2008
1	Osteoarthritis 12/2007
1	Rheumatoid Arthritis 12/2007
1	Paragonimiasis 07/2004
1	Eosinophilia 03/2003

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 01/2021 - 03/2003
5	InterleukinsIBA 01/2023 - 03/2003
5	AllergensIBA 11/2022 - 07/2007
5	EnzymesIBA 09/2020 - 01/2012
5	ImmunosorbentsIBA 09/2020 - 01/2012
4	Interleukin-5 (Interleukin 5)IBA 12/2021 - 03/2003
4	CytokinesIBA 01/2021 - 01/2012
3	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2023 - 03/2003
3	Immunoglobulin E (IgE)IBA 11/2022 - 07/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 09/2013
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	Interleukin-13IBA 12/2021 - 09/2020
2	Interleukin-33IBA 12/2021 - 12/2017
2	PeriostinIBA 09/2020 - 10/2018
2	Interleukin-17 (Interleukin 17)IBA 10/2018 - 02/2010
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 01/2007
2	Chemotactic FactorsIBA 01/2012 - 01/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2011 - 03/2011
2	LigandsIBA 09/2008 - 07/2005
1	TriazolesIBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 11/2022
1	Neuraminidase (Sialidase)IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2020
1	N 30IBA 10/2018
1	Chemokine CCL5IBA 12/2013
1	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2013
1	InterferonsIBA 12/2013
1	ChemokinesIBA 10/2013
1	LeukotrienesIBA 10/2013
1	Budesonide (Pulmicort)FDA LinkGeneric 09/2013
1	Formoterol Fumarate (Oxis)FDA Link 09/2013
1	CollagenIBA 04/2013
1	Therapeutic UsesIBA 01/2012
1	Interleukin-1 (Interleukin 1)IBA 02/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	Apolipoproteins E (ApoE)IBA 02/2009
1	Integrin alpha2IBA 09/2008
1	Integrin alpha1IBA 09/2008
1	Galectins (Galectin)IBA 12/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Theophylline (Theon)FDA LinkGeneric 01/2007
1	Interleukin-8 (Interleukin 8)IBA 01/2007
1	Chemokine CCL17IBA 07/2004

Therapy/Procedure

2	Intranasal Administration 12/2021 - 01/2012
1	Intraperitoneal Injections 01/2021
1	Immunotherapy 07/2017
1	Therapeutics 12/2013